Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Primary Myelofibrosis 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1

Interventions

Specimen Handling 122pembrolizumab 118Magnetic Resonance Spectroscopy 107Carboplatin 86Cyclophosphamide 75Biopsy 68Cisplatin 63Paclitaxel 58Bevacizumab 56Gemcitabine 49Nivolumab 47fludarabine 44Dexamethasone 39Rituximab 38Pemetrexed 38Fluorouracil 37atezolizumab 36Docetaxel 36Doxorubicin 34Radiotherapy 33Leucovorin 33venetoclax 31Oxaliplatin 30Capecitabine 30Temozolomide 28Prednisone 28Standard of Care 27Radiation 27Letrozole 27Cetuximab 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Hyperbaric Oxygenation × 30 days × Clear all
NCT03964506 2026-06-03

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

University of Rochester

Phase EARLY_PHASE1 Recruiting
24 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡